Imetelstat
Geron Corporation
['mds']
$gern geron announces asco presentation reporting durable continuous transfusion independence with imetelstat in imerge phase 3 lower risk mds patients #clinicaltrial 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i